|
|
|
| Introduction on the experience of Professor Qiu Xiangzhong in treating ankylosing spondylitis |
| XUE Fan1 DENG Hao1 DENG Milang1 QIU Xiangzhong2 |
1.Graduate College, Hu′nan University of Chinese Medicine, Hu'nan Province, Changsha 410208, China;
2.the First Department of Orthopedics, the Affiliated Hospital of Hu'nan Academy of Chinese Medicine, Hu′nan Province, Changsha 410006, China |
|
|
|
Abstract Ankylosing spondylitis is clinical common chronic inflammatory autoimmune disease, which is called “Da Lou” in traditional Chinese medicine and is popular in adolescence. Professor Qiu Xiangzhong has engaged in clinical work of traditional Chinese medicine for more than 35 years, who has rich experience for the treatment of this disease. Professor Qiu Xiangzhong believes that this disease is deficient in origin and excessive in superficiality. The origin is kidney and Du-meridian deficiency, while the superficiality is static blood blocking collaterals. Professor Qiu Xiangzhong lays emphasis on cold and heat as the main link to carry out treatment by stages in clinic, he is specialized in mild tonification, initiates that kidney, liver, spleen should be tonified at the same time, he is good at using parasitic drugs and medicinal guide drugs, which has received good clinical effects. It is worthy of promotion.
|
|
|
|
|
|
[1] van der Weijden MA，Claushuis TA，Nazari T，et al. High prevalence of low bone mineral density in patients within 10 years of onset of ankylosing spondylitis：a systematic review [J]. Clin Rheumatol，2012，31（11）：1529-1535.
[2] Feldtkeller E，Khan MA，van der Heijde D，et al. Age at disease onset and diagnosis delay in HLA-B27 negative vs positive patients with ankylosing spondylitis [J]. Rheumatol lnt，2003，23（2）：61-66.
[3] 中华医学会风湿病学分会.强直性脊柱炎诊断及治疗指南[J].中华风湿病学杂志，2010，14（8）：557-559.
[4] 李满意，杨林江，岳荣华.男性和女性强直性脊柱炎临床特点对比分析[J].中国医药导报，2008，5（31）：39-40.
[5] 汪年松，薛勤.强直性脊柱炎[M].2版.上海：上海交通大学出版社，2015：1-2.
[6] van der Linden S，Valkenburg HA，Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria [J]. Arthritis Rheum，1984，27（4）：361-368.
[7] Tam LS，Gu J，Yu D. Pathogenesis of ankylosing spondylitis [J]. Nat Rev Rheumatol，2015，22（2）：399-405.
[8] 阎小萍.强直性脊柱炎[M].北京：中国医药科技出版社，2004：23-36.
[9] ?魻■rendik M. Oral Anaerobic Bacteria in the Etiology of Ankylosing Spondylitis [J]. Clin Med Insights Arthritis Musculoskelet Disord，2017，10：1179544117712992.
[10] 戴小良，郑聪，宋利梅，等.南蛇藤合剂治疗强直性脊柱炎的时效性研究[J].湖南中医药大学学报，2017，37（9）：992-997.
[11] 姜楠，冯兴华，王冬峰，等.冯兴华教授治疗强直性脊柱炎用药规律分析[J].吉林中医药，2012，32（5）：510-513.
[12] 方利，刘健，朱福兵，等.基于细胞因子NF-κB信号通路探讨强直性脊柱炎患者血液高凝状态形成的机制[J].中华中医药杂志，2016，31（9）：3756-3759.
[13] 娄玉钤，娄高峰，娄多峰.基于虚邪瘀理论的风湿病学科体系建立及相关研究[J].风湿病与关节炎，2012，1（1）：10-15.
[14] 姜楠，冯兴华，何松蔚，等.强直性脊柱炎患者血小板计数变化及中药干预作用的临床研究[J].吉林中医药，2012， 32（7）：692-695.
[15] 冯兴华，姜泉，刘宏潇，等.中医辨证治疗强直性脊柱炎的临床疗效评价[J].中国中西医结合杂志，2013，33（10）：1309-1314.
[16] 魏宗星，李慧英，周金良，等.强直性脊柱炎从肝脾肾论治的理论浅析[J].中国中医药现代远程教育，2015，13（4）：10-11.
[17] 韩曼，姜泉，路志正.路志正治疗强直性脊柱炎经验[J].中医杂志，2016，57（19）：1634-1636.
[18] 陈月月，汪悦.阳和汤加减调节强直性脊柱炎T细胞功能及骨代谢指标的探讨[J].风湿病与关节炎，2013，2（10）：23-28.
[19] 汪庆华.益肾蠲痹丸治疗强直性脊柱炎的临床效果分析[J].中国医药科学，2017，7（19）：240-242.
[20] 方利，刘健，朱福兵，等.强直性脊柱炎血瘀证从脾肾论治探[J].辽宁中医杂志，2015，42（11）：2114-2115.
[21] 陈伯胜，王海东，金芳梅，等.强直性脊柱炎与相关经络关系研究[J].西部中医药，2017，30（3）：60-62.
[22] 孙晓涛，康武林，陈斌，等.搜剔通络虫类药在骨伤科中的应用[J].吉林中医药，2017，37（12）：1291-1294. |
|
|
|
